Syra Health Delivers Third Consecutive Profitable Quarter: Record Revenue of $2.6 Million, Up 52%, and 46.3% Gross Margin
Syra Health reported its third consecutive profitable quarter, with record Q3 2026 revenue of $2.6 million, up 52% year-over-year. Gross margin hit a company-record 46.3%, up 1,340 basis points, while EPS swung to $0.02 from a $(0.02) loss and EBITDA turned positive at $301,725. Nine-month operating cash flow reached $975,023 and cash sits at $2.4 million with no long-term debt; the company remains on track for full-year 2026 profitability.
Key figures
- Eps
- 0.02
- Revenue
- 2557295
- Guidance
- on track to achieve full-year profitability in 2026; expects quarter-to-quarter variability from RFP/contract timing
- Revenue Yoy
- 52%
- Ebitda
- 301725
- Net income
- 344610
- Gross margin
- 46.3%
- Workforce revenue
- 613507
- Cash and equivalents
- 2383413
- Net income nine months
- 835831
- Population health revenue
- 1943788
- Gross margin yoy bps change
- 1340
- Operating cash flow nine months
- 975023
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.